Northeast Pharmaceutical Group Co Ltd
SZSE:000597
Northeast Pharmaceutical Group Co Ltd
SZSE:000597
Price:
4.66 CNY
1.75%
Market Closed
Updated:
Apr 29, 2024
Northeast Pharmaceutical Group Co Ltd
Operating Income
|
Northeast Pharmaceutical Group Co Ltd
Operating Income Peer Comparison
Comparables:
C
1093
H
3692
600436
600276
000538
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Northeast Pharmaceutical Group Co Ltd
SZSE:000597
|
Operating Income
¥408.5m
|
CAGR 3-Years
23%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Operating Income
¥7.7B
|
CAGR 3-Years
12%
|
CAGR 5-Years
16%
|
CAGR 10-Years
23%
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Operating Income
¥3.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Operating Income
¥3.3B
|
CAGR 3-Years
22%
|
CAGR 5-Years
22%
|
CAGR 10-Years
21%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Operating Income
¥3.6B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
10%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Operating Income
¥3.7B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
6%
|
See Also
What is Northeast Pharmaceutical Group Co Ltd's Operating Income?
Operating Income
408.5m
CNY
408.5m
CNY
Based on the financial report for Dec 31, 2023, Northeast Pharmaceutical Group Co Ltd's Operating Income amounts to 408.5m CNY.
What is Northeast Pharmaceutical Group Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
15%
15%
Over the last year, the Operating Income growth was 61%. The average annual Operating Income growth rates for Northeast Pharmaceutical Group Co Ltd have been 23% over the past three years , 15% over the past five years .
You don't have any saved screeners yet
